# FDA Inspection 1122292 - Northwestern Medicine Central DuPage Hospital - February 04, 2020

Source: https://www.keypedia.com/records/fda_inspections/northwestern-medicine-central-dupage-hospital/e45d9bac-6b82-48cb-92af-b3e50dfdf924
Source feed: FDA_Inspections

> FDA Inspection 1122292 for Northwestern Medicine Central DuPage Hospital on February 04, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122292
- Company Name: Northwestern Medicine Central DuPage Hospital
- Inspection Date: 2020-02-04
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1246188 - 2024-08-07](https://www.keypedia.com/records/fda_inspections/northwestern-medicine-central-dupage-hospital/729d03bc-c372-49ae-982a-c30f99d5f16c)
- [FDA Inspection 1081078 - 2019-02-22](https://www.keypedia.com/records/fda_inspections/northwestern-medicine-central-dupage-hospital/59b7357e-2d81-49d9-9294-f8ea265b97d6)
- [FDA Inspection 1081078 - 2019-02-22](https://www.keypedia.com/records/fda_inspections/northwestern-medicine-central-dupage-hospital/e45bd9ec-388e-4116-b336-5adde572dccb)
- [FDA Inspection 985177 - 2015-12-22](https://www.keypedia.com/records/fda_inspections/northwestern-medicine-central-dupage-hospital/ee02a344-d74a-467b-8c5e-ab1cebd8ee82)
- [FDA Inspection 610717 - 2009-08-24](https://www.keypedia.com/records/fda_inspections/northwestern-medicine-central-dupage-hospital/31bfe2af-e0df-4816-abfb-2a1ebc8705ee)

Company: https://www.keypedia.com/companies/northwestern-medicine-central-dupage-hospital/d04451ef-7604-49a5-8df5-97b5adb87b96

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d